Idifarma Desarrollo Farmacéutico
Pharmaceutical CDMO | High Potent Drug Development | Idifarma.
Launch date
Employees
Company register number B31732399
Pamplona Navarre (HQ & founding location)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenues | 4.3m | 5.3m | 5.9m | 5.9m | 7.0m | 7.1m |
| % growth | - | 25 % | 10 % | 1 % | 17 % | 1 % |
| EBITDA | <1m | 1.0m | 1.1m | <1m | (<1m) | <1m |
| % EBITDA margin | 22 % | 20 % | 18 % | 4 % | (6 %) | 4 % |
| Profit | <1m | <1m | <1m | (<1m) | (1.2m) | (<1m) |
| % profit margin | 5 % | 7 % | 4 % | (8 %) | (17 %) | (12 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Early VC | |
N/A | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Idifarma Desarrollo Farmacéutico
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.